Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Nature Immunology|February 6, 2004
B cell receptor signal strength determines B cell fateStefano Casola, Kevin L Otipoby, Marat Alimzhanov, et al.Bioorganic & Medicinal Chemistry Letters|February 11, 2010
Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitorsStephanos Ioannidis, Michelle L Lamb, Lynsie Almeida, et al.Bioorganic & Medicinal Chemistry Letters|October 28, 2009
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitorsStephanos Ioannidis, Michelle L Lamb, Audrey M Davies, et al.Immunity|June 30, 2007
B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunityLily I Pao, Kong-Peng Lam, Joel M Henderson, et al.Bioorganic & Medicinal Chemistry Letters|April 16, 2011
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitorsTao Wang, Stephanos Ioannidis, Lynsie Almeida, et al.Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Discovery of novel Jak2-Stat pathway inhibitors with extended residence time on targetHuiping Guan, Michelle L Lamb, Bo Peng, et al.Oncotarget|June 2, 2016
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinomaXiaoen Wang, Nicolas Solban, Prateek Khanna, et al.Cancer Immunology Research|December 13, 2023
M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver InflammationChunxiao Xu, Xueyuan Zhou, Lindsay Webb, et al.ACS Medicinal Chemistry Letters|March 18, 2016
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.Journal of Medicinal Chemistry|December 24, 2013
Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitorsQibin Su, Stephanos Ioannidis, Claudio Chuaqui, et al.Pageof 2